Compare SGHT & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | XRX |
|---|---|---|
| Founded | 2011 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 309.6M | 368.8M |
| IPO Year | 2021 | 2019 |
| Metric | SGHT | XRX |
|---|---|---|
| Price | $5.30 | $2.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $9.08 | $2.50 |
| AVG Volume (30 Days) | 197.8K | ★ 3.5M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.31% |
| EPS Growth | ★ 28.16 | 23.26 |
| EPS | ★ N/A | N/A |
| Revenue | $77,363,000.00 | ★ $117,000,000.00 |
| Revenue This Year | $11.67 | $8.96 |
| Revenue Next Year | $10.39 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.11 | $1.19 |
| 52 Week High | $9.24 | $6.80 |
| Indicator | SGHT | XRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.94 | 41.76 |
| Support Level | $4.76 | $2.26 |
| Resistance Level | $5.74 | $2.89 |
| Average True Range (ATR) | 0.35 | 0.23 |
| MACD | -0.04 | -0.07 |
| Stochastic Oscillator | 38.80 | 15.38 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Xerox Holdings Corp is a workplace technology company, building and integrating services-led, software-enabled, workplace solutions for enterprises large and small. It provide advance document technology, services, software, and integrated IT infrastructure solutions for a range of customers including small and mid-sized businesses, large enterprises, governments and graphic communications providers, and for partners who serve them. Xerox serves customers globally in North America, Europe, Latin America, Brazil, Asia Pacific (APAC), the Middle East, Africa, and India.